Goni; Fernando

Patent Applications and Registrations

Patent applications and USPTO patent grants for Goni; Fernando.The latest application filed is for "specific murine and humanized monoclonal antibodies detecting pathology associated secondary structure changes in proteins and peptides".

Company Profile

2.11.12

Goni; Fernando - New York NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, non-amyloidogenic polymerized proteins and peptides Grant 11,332,506 - Wisniewski , et al. May 17, 2	2022-05-17
Specific Murine And Humanized Monoclonal Antibodies Detecting Pathology Associated Secondary Structure Changes In Proteins And Peptides App 20210324110 - WISNIEWSKI; Thomas M. ; et al.	2021-10-21
Specific murine and humanized monoclonal antibodies detecting pathology associated secondary structure changes in proteins and peptides Grant 10,870,709 - Wisniewski , et al. December 22, 2	2020-12-22
Immunotherapeutic Modulation Of Amyloidogenic Disease Using Non-fibrillogenic, Non-amyloidogenic Polymerized Proteins And Peptid App 20190338004 - Wisniewski; Thomas M. ; et al.	2019-11-07
Specific Murine And Humanized Monoclonal Antibodies Detecting Pathology Associated Secondary Structure Changes In Proteins And P App 20190256612 - WISNIEWSKI; Thomas M. ; et al.	2019-08-22
Immunotherapy targeting of the shared abnormal conformational state of amyloidogenic peptides/proteins Grant 10,253,070 - Wisniewski , et al.	2019-04-09
Immunotherapy Targeting Of The Shared Abnormal Conformational State Of Amyloidogenic Peptides/proteins App 20180305407 - WISNIEWSKI; Thomas M. ; et al.	2018-10-25
Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, non-amyloidogenic polymerized proteins and peptides Grant 9,926,353 - Wisniewski , et al. March 27, 2	2018-03-27
Immunotherapy targeting of the shared abnormal conformational state of amyloidogenic peptides/proteins Grant 9,834,582 - Wisniewski , et al. December 5, 2	2017-12-05
Method for treating amyloid disease Grant 9,770,496 - Wisniewski , et al. September 26, 2	2017-09-26
Method For Treating Amyloid Disease App 20160303208 - WISNIEWSKI; Thomas ; et al.	2016-10-20
Method for treating amyloid disease Grant 9,295,719 - Wisniewski , et al. March 29, 2	2016-03-29
Method for Treating Amyloid Disease App 20150165005 - WISNIEWSKI; Thomas ; et al.	2015-06-18
Immunotherapy Targeting Of The Shared Abnormal Conformational State Of Amyloidogenic Peptides/proteins App 20150147334 - Wisniewski; Thomas M. ; et al.	2015-05-28
Immunotherapy targeting of the shared abnormal conformational state of amyloidogenic peptides/proteins Grant 8,951,519 - Wisniewski , et al. February 10, 2	2015-02-10
Immunotherapy Targeting Of The Shared Abnormal Conformational State Of Amyloidogenic Peptides/proteins App 20130156783 - Wisniewski; Thomas M. ; et al.	2013-06-20
Immunotherapy targeting of the shared abnormal conformational state of amyloidogenic peptides/proteins Grant 8,409,584 - Wisniewski , et al. April 2, 2	2013-04-02
Immunotherapeutic Modulation Of Amyloidogenic Disease Using Non-fibrillogenic, Non-amyloidogenic Polymerized Proteins And Peptides App 20130022544 - Wisniewski; Thomas M. ; et al.	2013-01-24
Immunotherapy Targeting Of The Shared Abnormal Conformational State Of Amyloidogenic Peptides/proteins App 20100284909 - Wisniewski; Thomas M. ; et al.	2010-11-11

Company Registrations

SEC

0001634908

GONI FERNANDO

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.